241 related articles for article (PubMed ID: 20542018)
1. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.
Ivanova M; Artusi C; Boffa GM; Zaninotto M; Plebani M
Clin Chim Acta; 2010 Nov; 411(21-22):1632-6. PubMed ID: 20542018
[TBL] [Abstract][Full Text] [Related]
2. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
Brooks ER; Langman CB; Wang S; Price HE; Hodges AL; Darling L; Yang AZ; Smith FA
Pediatr Nephrol; 2009 Jan; 24(1):129-34. PubMed ID: 18830716
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
Di Gangi IM; Chiandetti L; Gucciardi A; Moret V; Naturale M; Giordano G
Anal Chim Acta; 2010 Sep; 677(2):140-8. PubMed ID: 20837180
[TBL] [Abstract][Full Text] [Related]
4. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
5. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
[TBL] [Abstract][Full Text] [Related]
6. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
[TBL] [Abstract][Full Text] [Related]
8. Symmetric Dimethylarginine Assay Validation, Stability, and Evaluation as a Marker for the Early Detection of Chronic Kidney Disease in Dogs.
Nabity MB; Lees GE; Boggess MM; Yerramilli M; Obare E; Yerramilli M; Rakitin A; Aguiar J; Relford R
J Vet Intern Med; 2015; 29(4):1036-44. PubMed ID: 26079532
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
Oliva-Damaso E; Oliva-Damaso N; Rodriguez-Esparragon F; Payan J; Baamonde-Laborda E; Gonzalez-Cabrera F; Santana-Estupiñan R; Rodriguez-Perez JC
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357472
[TBL] [Abstract][Full Text] [Related]
10. Associations between endogenous dimethylarginines and renal function in healthy children and adolescents.
Jaźwińska-Kozuba A; Martens-Lobenhoffer J; Surdacki A; Kruszelnicka O; Rycaj J; Godula-Stuglik U; Bode-Böger SM
Int J Mol Sci; 2012 Nov; 13(11):15464-74. PubMed ID: 23203136
[TBL] [Abstract][Full Text] [Related]
11. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
[TBL] [Abstract][Full Text] [Related]
12. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
Ronden RA; Houben AJ; Teerlink T; Bakker JA; Bierau J; Stehouwer CD; De Leeuw PW; Kroon AA
Am J Physiol Renal Physiol; 2012 Jul; 303(1):F149-56. PubMed ID: 22552932
[TBL] [Abstract][Full Text] [Related]
13. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
[TBL] [Abstract][Full Text] [Related]
14. HPLC analysis of asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine in small plasma volumes using a Gemini-NX column at high pH.
Jones CE; Darcy CJ; Woodberry T; Anstey NM; McNeil YR
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):8-12. PubMed ID: 19945921
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.
Fleck C; Schweitzer F; Karge E; Busch M; Stein G
Clin Chim Acta; 2003 Oct; 336(1-2):1-12. PubMed ID: 14500028
[TBL] [Abstract][Full Text] [Related]
16. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
[TBL] [Abstract][Full Text] [Related]
17. The role of asymmetric and symmetric dimethylarginines in renal disease.
Schwedhelm E; Böger RH
Nat Rev Nephrol; 2011 May; 7(5):275-85. PubMed ID: 21445101
[TBL] [Abstract][Full Text] [Related]
18. Dimethylarginines as risk markers of atherosclerosis and chronic kidney disease in children with nephrotic syndrome.
Hyla-Klekot L; Bryniarski P; Pulcer B; Ziora K; Paradysz A
Adv Clin Exp Med; 2015; 24(2):307-14. PubMed ID: 25931365
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
20. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
Hov GG; Aasarød KI; Sagen E; Åsberg A
Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
